Paroxysmal Supraventricular Tachycardia Following Ondansentron Intravenous Administration: A Case Report
Erick Hoetama
Abstract
Open-access reader
Erick Hoetama
Abstract
Open-access reader
Ondasentron is selective serotonin 5-HT3 receptor antagonist.It is widely used as the drug of choice for preventing nausea and vomiting associated with chemotheraphy and post-surgery.This drug become more popular because it's superior efficacy and minimal side effect.Although cardiovascular adverse effect caused by ondansentron administration is rare, some cardiovascular events have been reported, from atrial fibrillation to fatal ventricular tachycardia.This case reports paroxysmal supraventricular tachycardia in male 23 years old following administration of 4 mg intravenous ondansentron.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Ondasentron is selective serotonin 5-HT3 receptor antagonist.It is widely used as the drug of choice for preventing nausea and vomiting associated with chemotheraphy and post-surgery.This drug become more popular because it's superior efficacy and minimal side effect.Although cardiovascular adverse effect caused by ondansentron administration is rare, some cardiovascular events have been reported, from atrial fibrillation to fatal ventricular tachycardia.This case reports paroxysmal supraventricular tachycardia in male 23 years old following administration of 4 mg intravenous ondansentron.
Key concepts: Medicine, Administration (probate law), Supraventricular tachycardia, Paroxysmal supraventricular tachycardia, Cardiology, Tachycardia, Anesthesia, Internal medicine